Neville AM - Search Results

1

Cancer-testis antigen expression in triple-negative breast cancer.

Curigliano G, Viale G, Ghioni M, Jungbluth AA, Bagnardi V, Spagnoli GC, Neville AM, Nolè F, Rotmensz N, Goldhirsch A. Curigliano G, et al. Among authors: neville am. Ann Oncol. 2011 Jan;22(1):98-103. doi: 10.1093/annonc/mdq325. Epub 2010 Jul 7. Ann Oncol. 2011. PMID: 20610479 Free article.

2

Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group.

Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B, Neville AM. Cote RJ, et al. Among authors: neville am. Lancet. 1999 Sep 11;354(9182):896-900. doi: 10.1016/s0140-6736(98)11104-2. Lancet. 1999. PMID: 10489948 Clinical Trial.

3

Breast cancer micrometastases in lymph nodes and bone marrow are prognostically important.

Neville AM. Neville AM. Ann Oncol. 1991 Jan;2(1):13-4. doi: 10.1093/oxfordjournals.annonc.a057812. Ann Oncol. 1991. PMID: 2009231 Free article. Review. No abstract available.

4

Axillary node micrometastases and breast cancer.

Neville AM, Price KN, Gelber RD, Goldhirsch A. Neville AM, et al. Lancet. 1991 May 4;337(8749):1110. doi: 10.1016/0140-6736(91)91768-p. Lancet. 1991. PMID: 1673541 No abstract available.

5

Occult axillary lymph-node micrometastases in breast cancer.

Neville AM, Bettelheim R, Gelber RD, Goldhirsch A. Neville AM, et al. Lancet. 1990 Sep 22;336(8717):759. doi: 10.1016/0140-6736(90)92262-g. Lancet. 1990. PMID: 1975938 No abstract available.

6

Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group.

Neville AM, Bettelheim R, Gelber RD, Säve-Söderbergh J, Davis BW, Reed R, Torhorst J, Golouh R, Peterson HF, Price KN, et al. Neville AM, et al. J Clin Oncol. 1992 May;10(5):696-705. doi: 10.1200/JCO.1992.10.5.696. J Clin Oncol. 1992. PMID: 1569442 Clinical Trial.

7

The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis.

Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC, Neville AM. Berger U, et al. Among authors: neville am. Am J Clin Pathol. 1988 Jul;90(1):1-6. doi: 10.1093/ajcp/90.1.1. Am J Clin Pathol. 1988. PMID: 3389336

8

LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma.

Liu D, Baltayan A, Naritoku WY, Barr NJ, Young LL, Chaiwun B, Tsao-Wei DD, Groshen SL, Taylor CR, Torloni H, Neville AM, Cote RJ, Imam SA. Liu D, et al. Among authors: neville am. Anticancer Res. 2000 May-Jun;20(3A):1451-61. Anticancer Res. 2000. PMID: 10928056

9

A sialoglycoprotein (LEA.135) associated with favourable prognosis of patients with lymph node-negative primary breast carcinoma.

Imam SA, Chaiwun B, Wang MJ, Morris MM, Groshen SG, Neville AM, Torloni H, Cote RJ, Taylor CR. Imam SA, et al. Among authors: neville am. Anticancer Res. 1996 Sep-Oct;16(5B):3043-8. Anticancer Res. 1996. PMID: 8920764

10

Biochemical and immunologic diagnosis of cancer. Breast cancer.

Neville AM, Coombes RC. Neville AM, et al. Tumour Biol. 1987;8(2-3):116-9. Tumour Biol. 1987. PMID: 3448762 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters